Literature DB >> 9331011

A comparison of the antihypertensive effects of candesartan cilexetil and losartan in patients with mild to moderate hypertension.

O K Andersson1, S Neldam.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9331011

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN： 0950-9240            Impact factor:   3.012


× No keyword cloud information.
  4 in total

Review 1.  An overview of candesartan in clinical practice.

Authors:  Zeeshan Khawaja; Christopher S Wilcox
Journal:  Expert Rev Cardiovasc Ther       Date:  2011-08

Review 2.  Candesartan cilexetil. A review of its use in essential hypertension.

Authors:  K J McClellan; K L Goa
Journal:  Drugs       Date:  1998-11       Impact factor: 9.546

3.  Candesartan cilexetil/hydrochlorothiazide combination treatment versus high-dose candesartan cilexetil monotherapy in patients with mild to moderate cardiovascular risk (CHILI Triple T).

Authors:  Gerd Bönner; Bernhard Landers; Peter Bramlage
Journal:  Vasc Health Risk Manag       Date:  2011-02-17

Review 4.  Management of hypertension with fixed dose combinations of candesartan cilexetil and hydrochlorothiazide: patient perspectives and clinical utility.

Authors:  Thomas Mengden; Sakir Uen; Peter Bramlage
Journal:  Vasc Health Risk Manag       Date:  2009-12-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.